Top compounds associated with response to AC010642.1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA SB-525334 CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA BRD-K16130065 CTRPv2 pan-cancer AAC -0.25 0.002
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA STF-31 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.004
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.005
Download CSV